Harmony Biosciences Inc. (HRMY)

HRMY trades at $27.28, 16.1% below the near-term max pain of $32.5 expiring Oct 17, 2025 (12 days). Look for upward drift as max pain acts as a magnet pulling price higher. Max pain is rising across expirations ($25-$35), reflecting growing call interest at higher strikes. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for HRMY shows an upward trend from 25 to 35, suggesting bullish positioning in longer-dated options. The 33% spread signals divergent expectations across timeframes. Most levels above 27.28 could support dips. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.